Companies: 10,795·Total market cap: $144.5T
Enovis Corporation

Enovis Corporation

ENOVNYSEHealthcare● Active
$24.06
+$0.28(+1.18%)
Market Cap$1.4B
P/E Ratio—
52W High$36.82
52W Low$20.82
Cash on HandFinancialsRevenue

Enovis Corporation (ENOV) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

ENOV · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$36.4M▼ -24.5% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$36.4M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-24.5%
vs prior fiscal year
Latest Quarter
$33.1M
Q2 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$36.4MCash on Hand
Total Debt$1.38BTotal Debt
Net Cash / Net Debt−$1.34BNet Debt Position
Cash vs Debt Ratio
Cash 3%Debt 97%

Enovis Corporation carries a net debt position of $1.34B. Total debt ($1.38B) exceeds cash on hand ($36.4M). Enovis Corporation cash vs debt ratio: 3% cash / 97% debt.

Net Cash = Cash & ST Investments − Total Debt$36.4M − $1.38B = −$1.34B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
ENOV annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$36.4M-24.5%
Dec 31, 2024$48.2M+33.1%
Dec 31, 2023$36.2M+49.0%
Dec 31, 2022$24.3M-96.4%
Dec 31, 2021$680.3M+573.1%
ENOV cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Enovis Corporation
Enovis CorporationYOU
ENOV
$36.4M2.6%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Enovis Corporation (ENOV) cash on hand as of December 31, 2025 is $36.4M, comprising $36.4M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Enovis Corporation cash and short-term investments on the balance sheet (10-K filing). Also referred to as Enovis Corporation cash reserves or cash position.

Enovis Corporation annual cash on hand history shows decreased -24.5% in 2025: decreased -24.5% in 2025. Enovis Corporation cash reserves in 2025 reflect the company's capital allocation strategy.

Enovis Corporation carries total debt of $1.38B against cash of $36.4M, resulting in a net debt position of -$1.34B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

ENOV cash on hand · 5 questions

As of December 31, 2025, Enovis Corporation (ENOV) has $36,389,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $36,389,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (April 3, 2026): $33,128,999. Data sourced from the annual 10-K filing via FMP.

ENOV cash on handENOV cash reservesENOV cash 2025how much cash does ENOV have

▸ Source: FMP /balance-sheet-statement · US GAAP · Enovis Corporation · Enovis Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025